Development of a Targeted Epigenome Modification Platform


Momentum Fellow (2022-2023)

Anand Divakaran, PhD, University of California, Berkeley

Anand Divakaran, PhD

Dr. Divakaran is developing novel induced-proximity-based therapeutic modalities for targeted editing of the epigenome to silence the expression of common cancer-causing genes.

BACK TO OUR PORTFOLIO